IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Scientific Publications

Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

Read more

Scientific Publications

Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines

Read more

Scientific Publications

Case Studies on Changes and Proposed Process Development Approaches Reflecting Applicability of PDA Technical Report No. 89: Strategies for Vaccine Development and Lifecycle Management

Read more

Features

Meet the Scientist: Dr. Gaudensia Mutua on IAVI’s Lassa fever vaccine development program

December 20, 2024

Gaudensia Mutua, a medical director with IAVI in Nairobi, Kenya, discusses her work in support of IAVI’s Lassa fever vaccine program.

Read more

Podcasts

Meet the Scientist Episode 5: Dr. Gaudensia Mutua on IAVI’s Lassa fever vaccine development program

December 19, 2024

In this episode of Meet the Scientist, IAVI’s podcast series, we sat down with Gaudensia Mutua, a medical director with IAVI in Nairobi, Kenya, to discuss her work in support of IAVI’s Lassa fever vaccine program. We delved into the value of community-engaged scientific research before looking ahead to the future of global health and vaccine development in Africa. Tune in to learn about Gaudensia’s rich medical career — from community-based HIV vaccine research to overseeing IAVI’s Lassa fever vaccine studies. Read the full transcription of the podcast.

Read more

Building and Enhancing Policy and Advocacy Skills of Civil Society Organizations, Community Based Organizations, Clinical Research Centers and Institutions in Biomedical Prevention Research — Training Manual

Developed in partnership with key stakeholders, this policy and advocacy training manual is designed to ensure that essential skills are shared and transferred among diverse audiences. Our goal is to build a critical mass of advocates who can influence policies and best practices in HIV prevention research and beyond.

Read more

Features

Access to monoclonal antibodies in Africa: A call to action

December 17, 2024

IAVI and Impact Global Health issue a renewed call to action to ensure equitable access to monoclonal antibodies.

Read more

Access to monoclonal antibodies in Africa: A call to action

A report from IAVI and Impact Global Health evaluating the current state of research and development and access for monoclonal antibodies (mAbs) and related products. The report, funded by Wellcome, is a four-year retrospective on the availability of mAbs and biosimilars globally — with new insights into the African region that could serve as a bellwether for progress globally.

Read more